World's Best Scientists 2026 revealed!
Jeffrey I. Weitz

Jeffrey I. Weitz

D-Index & Metrics

Medicine

D-Index
136
Citations
94765
World Ranking
1943
National Ranking
71

Research.com Recognitions

  • 2016 - Fellow of the Royal Society of Canada Academy of Science
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Jeffrey I. Weitz is affiliated with McMaster University in Canada and has a significant body of research in the field of medicine, particularly focusing on cardiology and cardiovascular medicine, internal medicine, and hematology. Their work spans multiple subfields including genetics and surgery, demonstrating a broad expertise across medical disciplines.

The primary research topics addressed by Weitz include:

  • Venous Thromboembolism Diagnosis and Management
  • Atrial Fibrillation Management and Outcomes
  • Blood Coagulation and Thrombosis Mechanisms
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Antiplatelet Therapy and Cardiovascular Diseases
  • COVID-19 Clinical Research Studies
  • Acute Myocardial Infarction Research

Among recent papers associated with the scientific community around Weitz are key publications including:

  • COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up, 2020, Journal of the American College of Cardiology
  • Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19, 2021, JAMA Internal Medicine
  • Therapeutic strategies for thrombosis: new targets and approaches, 2020, Nature Reviews Drug Discovery
  • Abelacimab for Prevention of Venous Thromboembolism, 2021, New England Journal of Medicine
  • Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research, 2020, Thrombosis and Haemostasis

Frequently collaborating with other researchers, Weitz has coauthored publications alongside:

  • Walter Ageno
  • Samuel Z. Goldhaber
  • James C. Fredenburgh
  • Shinya Goto
  • Pantep Angchaisuksiri

Weitz's work commonly appears in journals such as:

  • Journal of Thrombosis and Haemostasis
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Thrombosis and Haemostasis
  • Research and Practice in Thrombosis and Haemostasis
  • Thrombosis Research

Notable recognitions in their career include being named a Fellow of the Royal Society of Canada in 2016, within the Academy of Science, and membership in the Association of American Physicians.

Best Publications

  • Edoxaban versus warfarin in patients with atrial fibrillation

    Robert P. Giugliano;Christian T. Ruff;Eugene Braunwald;Sabina A. Murphy

  • Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

    Christian T Ruff;Robert P Giugliano;Eugene Braunwald;Elaine B Hoffman

  • COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

    Behnood Bikdeli;Mahesh V. Madhavan;David Jimenez;Taylor Chuich

  • Oral Apixaban for the Treatment of Acute Venous Thromboembolism

    Giancarlo Agnelli;Harry R. Buller;Alexander Cohen;Madelyn Curto

  • Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer

    Philip S. Wells;David R. Anderson;Marc Rodger;Jeffrey S. Ginsberg

  • Low-Molecular-Weight Heparins

    Jeffrey I. Weitz

  • Idarucizumab for Dabigatran Reversal

    Charles V. Pollack;Paul A. Reilly;John Eikelboom;Stephan Glund

  • A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.

    Mark Levine;Michael Gent;Jack Hirsh;Jacques Leclerc

  • Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events

    John W. Eikelboom;Jack Hirsh;Jeffrey I. Weitz;Marilyn Johnston

  • Apixaban for Extended Treatment of Venous Thromboembolism

    Giancarlo Agnelli;Harry R. Buller;Alexander Cohen;Madelyn Curto

  • Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

    Gary E. Raskob;Nick van Es;Peter Verhamme;Marc Carrier

  • A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

    Clive Kearon;Michael Gent;Michael Gent;Jack Hirsh;Jack Hirsh;Jeffrey Weitz

  • Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.

    J I Weitz;M Hudoba;D Massel;J Maraganore

  • Use of a clinical model for safe management of patients with suspected pulmonary embolism.

    Philip S. Wells;Jeffrey S. Ginsberg;David R. Anderson;Clive Kearon

  • Diagnosis and Treatment of Chronic Arterial Insufficiency of the Lower Extremities: A Critical Review

    Weitz Ji;Byrne J;Clagett Gp;Farkouh Me

  • Parenteral Anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

    David A. Garcia;Trevor P. Baglin;Jeffrey I. Weitz;Meyer Michel Samama

  • Thrombosis A Major Contributor to Global Disease Burden

    G.E. Raskob;P. Angchaisuksiri;A.N. Blanco;H. Buller

  • Comparison of Low-Intensity Warfarin Therapy With Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism

    Clive Kearon;Jeffrey S. Ginsberg;Michael J. Kovacs;David R. Anderson

  • Idarucizumab for Dabigatran Reversal — Full Cohort Analysis

    Charles V. Pollack;Paul A. Reilly;Joanne van Ryn;John W. Eikelboom

  • Accuracy of clinical assessment of deep-vein thrombosis

    PhilipS. Wells;Jack Hirsh;DavidR. Anderson;AnthonyW.A. Lensing

Frequent Co-Authors

John W. Eikelboom
John W. Eikelboom Population Health Research Institute
Jack Hirsh
Jack Hirsh McMaster University
Gary E. Raskob
Gary E. Raskob University of Oklahoma Health Sciences Center
Harry R. Büller
Harry R. Büller University of Amsterdam
Jeffrey S. Ginsberg
Jeffrey S. Ginsberg McMaster University
Alexander G.G. Turpie
Alexander G.G. Turpie McMaster University
Walter Ageno
Walter Ageno University of Insubria
Paolo Prandoni
Paolo Prandoni University of Padua
Philip S. Wells
Philip S. Wells Ottawa Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine doesn’t have to be limited by traditional, in-person degrees. Aspiring healthcare professionals can find a variety of online programs designed to fit different goals and schedules. For instance, if you're looking to advance your nursing career quickly, consider the shortest dnp programs online that let you earn a Doctor of Nursing Practice degree on an accelerated timeline.

For those seeking a more manageable academic workload, easiest dnp program online options can make advancing your credentials more accessible. If you’re starting out, lpn programs offer a fast track into nursing, allowing you to begin working in the medical field sooner.

Nurses with a BSN can also find advanced specialized pathways. Consider bsn to np programs online for opportunities to become a nurse practitioner, opening doors to high-demand specialties like psychiatric and mental health.

No matter your background or professional goals, online degrees can provide flexible, efficient routes into fulfilling healthcare careers.

Best Scientists Citing Jeffrey I. Weitz

Trending Scientists